PRK (febrero 2026)/ CME GLOBEX
PRK- - | Diferencia - | Apertura | Máximo del día | Price Change Band | Cierre del día anterior |
---|---|---|---|---|---|
-USD | - | - | - | - | - |
GlobeNewswire
22/07/2024
Park National Corporation reports financial results for second quarter and first half of 2024
GlobeNewswire
21/05/2024
Park National Corporation welcomes Kelly Gratz and Karen Morrison to Board of Directors
GlobeNewswire
11/04/2024
First Patient Enrolled in LYNX-2 Phase 3 Study Evaluating Phentolamine Ophthalmic Solution 0.75% (PS...
GlobeNewswire
19/01/2024
Regency Centers Announces Tax Information for Regency Centers and Urstadt Biddle Properties 2023 Dis...
GlobeNewswire
23/10/2023
Park National Corporation reports financial results for third quarter and first nine months of 2023
GlobeNewswire
28/03/2022
EVO VISIAN® ICL NOW AVAILABLE IN THE US: PARKHURST NUVISION OF SAN ANTONIO TEXAS AMONG FIRST IN THE ...
GlobeNewswire
21/12/2021
Park National Corporation welcomes D. Byrd Miller III to Board of Directors
GlobeNewswire
15/11/2021
Kiora Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update
GlobeNewswire
08/11/2021
EyeGate is Now Kiora Pharmaceuticals; Provides Update on Company’s Sharpened Clinical Development St...
GlobeNewswire
29/10/2021
Physician Growth Partners Advises Griffey Eye Care & Their Affiliated Entities in a Partnership With...
GlobeNewswire
26/10/2021
EyeGate Pharmaceuticals Appoints Eric J. Daniels, MD, MBA, as Chief Development Officer and Closes A...
GlobeNewswire
25/10/2021
Park National Corporation reports financial results for third quarter and first nine months of 2021
GlobeNewswire
04/10/2021
Agrify Acquires Precision Extraction Solutions and Cascade Sciences, Two of the Leading Cannabis and...
GlobeNewswire
09/09/2021
EyeGate to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
GlobeNewswire
08/09/2021
EyeGate Pharma Completes Target Enrollment in Phase 2 Proof-of-Concept Study to Evaluate PP-001 for ...
GlobeNewswire
30/07/2021
Park National Corporation welcomes Dr. Frederic Bertley to board of directors
GlobeNewswire
26/07/2021
EyeGate Pharmaceuticals Announces Appointment of Brian M. Strem, Ph.D., as President and Chief Execu...
GlobeNewswire
26/07/2021
Park National Corporation reports financial results for second quarter and first half of 2021
GlobeNewswire
26/04/2021
Park National Corporation leader Daniel DeLawder announces retirement after 50 years of service
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página